Advertisement
Advertisement
U.S. Markets open in 9 hrs 16 mins
Advertisement
Advertisement
Advertisement
Advertisement

Laboratory Corporation of America Holdings (LH)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
248.55+2.12 (+0.86%)
At close: 04:00PM EDT
Advertisement

Laboratory Corporation of America Holdings

531 South Spring Street
Burlington, NC 27215
United States
844 625 0967
https://www.labcorp.com

Sector(s)Healthcare
IndustryDiagnostics & Research
Full Time Employees75,000

Key Executives

NameTitlePayExercisedYear Born
Mr. Adam H. SchechterPres, CEO & Chairman5.51MN/A1965
Mr. Glenn A. EisenbergCFO & Exec. VP2.3MN/A1961
Dr. Brian J. Caveney M.P.H., M.D., J.D., MPHExec. VP, Pres of Diagnostics & Chief Medical Officer1.57MN/A1974
Mr. Mark S. SchroederExec. VP and Pres of Diagnostics Laboratory Operations & Global Supply Chain1.59MN/A1961
Dr. Paul R. Kirchgraber M.D.Exec. VP & CEO of Covance Drug Devel.2.02MN/A1962
Dr. Michelle Abelson Ph.D.Laboratory Director of OperationsN/AN/AN/A
Mr. Peter J. WilkinsonSr. VP & Chief Accounting OfficerN/AN/A1972
Mr. Lance V. BerberianExec. VP and Chief Information & Technology OfficerN/AN/A1963
Dr. Marcia T. Eisenberg Ph.D.Chief Scientific Officer & Sr. VPN/AN/A1960
Chas CookVP of Investor RelationsN/AN/AN/A
Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Laboratory Corporation of America Holdings operates as an independent clinical laboratory company worldwide. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, Pap tests, hemoglobin A1C and vitamin D products, prostate-specific antigens, tests for sexually transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. The company also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases, including anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, and parentage and donor testing; and occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests. It provides online and mobile applications to enable patients to check test results; and online applications for managed care organizations. It offers end-to-end drug development, medical device, and diagnostic development solutions from early-stage research to clinical development and commercial market access. It serves managed care organizations, biopharmaceutical companies, physicians and other healthcare providers, hospitals and health systems, governmental agencies, employers, patients and consumers, contract research organizations, crop protection and chemical companies, academic institutions, and independent clinical laboratories. The company was founded in 1971 and is headquartered in Burlington, North Carolina.

Corporate Governance

Laboratory Corporation of America Holdings’s ISS Governance QualityScore as of May 1, 2022 is 1. The pillar scores are Audit: 8; Board: 7; Shareholder Rights: 1; Compensation: 1.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Advertisement
Advertisement